3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Osteosarcoma
3
Neuroblastoma
3
Breast Neoplasms
3
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer
1
Stomach Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Clear Cell
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Rhabdoid Tumor
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neuroectodermal Tumors, Primitive
1
Nerve Sheath Neoplasms
1
Neoplasm Metastasis
1
Myoepithelioma
1
Myelodysplastic Syndromes
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Acute
1
Leiomyosarcoma
1
Hodgkin Disease
1
Giant Cell Tumor of Bone
1
Desmoplastic Small Round Cell Tumor
1
Clear-cell metastatic renal cell carcinoma
1
Chordoma
1
Chondrosarcoma
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Breast Cancer Metastatic
1
Interventions
Temozolomide
18
Magnetic Resonance Spectroscopy
15
Specimen Handling
13
Radiotherapy
13
Radiation
9
Biopsy
5
pembrolizumab
4
Radiotherapy, Intensity-Modulated
4
Nivolumab
4
Bevacizumab
4
vorasidenib
3
trametinib
3
Surgical Procedures, Operative
3
Spinal Puncture
3
tovorafenib
2
dabrafenib
2
Restraint, Physical
2
Leukapheresis
2
Ipilimumab
2
Genetic Therapy
2
Fluorodeoxyglucose F18
2
Eflornithine
2
Craniotomy
2
Carboplatin
2
14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene
2
vocimagene amiretrorepvec
1
veliparib
1
trastuzumab deruxtecan
1
tocilizumab
1
ribociclib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Astrocytoma
×
Zoledronic Acid
×
1 year
×
Clear all
No trials found.